157 related articles for article (PubMed ID: 38336189)
1. Single-cell RNA sequencing reveals the MIF-ACKR3 receptor-ligand interaction between iCAFs and tumor cells in esophageal squamous cell carcinoma.
Liang J; Lei K; Liang R; Huang J; Tan B; Lin H; Wang M
Cell Signal; 2024 May; 117():111093. PubMed ID: 38336189
[TBL] [Abstract][Full Text] [Related]
2. Profiling transcriptional heterogeneity of epithelium, fibroblasts, and immune cells in esophageal squamous cell carcinoma by single-cell RNA sequencing.
Shi K; Li Y; Yang L; Zhang Z; Guo D; Zhang J; Lu Y
FASEB J; 2022 Nov; 36(11):e22620. PubMed ID: 36260317
[TBL] [Abstract][Full Text] [Related]
3. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
Li W; Xu T; Jin H; Li M; Jia Q
Pathol Res Pract; 2024 Jan; 253():155002. PubMed ID: 38056131
[TBL] [Abstract][Full Text] [Related]
6. Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma.
Guo W; Zhou B; Yang Z; Liu X; Huai Q; Guo L; Xue X; Tan F; Li Y; Xue Q; Gao S; He J
EBioMedicine; 2022 Oct; 84():104281. PubMed ID: 36162205
[TBL] [Abstract][Full Text] [Related]
7. Single-cell RNA-sequencing data reveals the genetic source of extracellular vesicles in esophageal squamous cell carcinoma.
Zhou B; Guo W; Guo L; Li Y; Zheng Z; Huai Q; Tan F; Li Y; Xue Q; Ying J; Zhao L; Gao S; He J
Pharmacol Res; 2023 Jun; 192():106800. PubMed ID: 37217040
[TBL] [Abstract][Full Text] [Related]
8. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma.
Chen Z; Zhao M; Liang J; Hu Z; Huang Y; Li M; Pang Y; Lu T; Sui Q; Zhan C; Lin M; Guo W; Wang Q; Tan L
EBioMedicine; 2021 Jul; 69():103459. PubMed ID: 34192657
[TBL] [Abstract][Full Text] [Related]
10. Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment.
Dinh HQ; Pan F; Wang G; Huang QF; Olingy CE; Wu ZY; Wang SH; Xu X; Xu XE; He JZ; Yang Q; Orsulic S; Haro M; Li LY; Huang GW; Breunig JJ; Koeffler HP; Hedrick CC; Xu LY; Lin DC; Li EM
Nat Commun; 2021 Dec; 12(1):7335. PubMed ID: 34921160
[TBL] [Abstract][Full Text] [Related]
11. The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma.
Zhang L; Ye SB; Ma G; Tang XF; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
J Transl Med; 2013 Mar; 11():60. PubMed ID: 23497377
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
Sui X; Chen C; Zhou X; Wen X; Shi C; Chen G; Liu J; He Z; Yao Y; Li Y; Gao Y
J Exp Clin Cancer Res; 2023 Feb; 42(1):51. PubMed ID: 36850011
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β.
Liu RM; Sun DN; Jiao YL; Wang P; Zhang J; Wang M; Ma J; Sun M; Gu BL; Chen P; Liu K; Ma H; Gao SG; Ma YF; Qi YJ
Cancer Lett; 2018 Jan; 412():289-296. PubMed ID: 29079416
[TBL] [Abstract][Full Text] [Related]
14. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-100-5p in cancer-associated fibroblast-derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma.
Chen C; Yang C; Tian X; Liang Y; Wang S; Wang X; Shou Y; Li H; Xiao Q; Shu J; Sun M; Chen K
Cancer Med; 2023 Jul; 12(13):14468-14483. PubMed ID: 37184125
[TBL] [Abstract][Full Text] [Related]
16. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
17. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
He JZ; Chen Y; Zeng FM; Huang QF; Zhang HF; Wang SH; Yu SX; Pang XX; Liu Y; Xu XE; Wu JY; Shen WJ; Li ZY; Li EM; Xu LY
J Exp Clin Cancer Res; 2023 May; 42(1):136. PubMed ID: 37254126
[TBL] [Abstract][Full Text] [Related]
18. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
20. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
